ARS Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • ARS Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -19.3 %, a 2.28% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Return On Assets for 2023 was -21.5 %, a 79.5% decline from 2022.
  • ARS Pharmaceuticals, Inc. annual Return On Assets for 2022 was -12 %, a 72% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -19.3 +0.45 +2.28% Apr 1, 2024 Jun 30, 2024
Q1 2024 -20.5 -5.36 -35.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -21.5 -9.52 -79.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.3 -34.1 -314% Jul 1, 2023 Sep 30, 2023
Q2 2023 -19.7 -23.4 -632% Apr 1, 2023 Jun 30, 2023
Q1 2023 -15.2 -12 -381% Jan 1, 2023 Mar 31, 2023
Q4 2022 -12 -5.01 -72% Oct 1, 2022 Dec 31, 2022
Q3 2022 10.9 +32 Jul 1, 2022 Sep 30, 2022
Q2 2022 3.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -3.16 Jan 1, 2022 Mar 31, 2022
Q4 2021 -6.96 Oct 1, 2021 Dec 31, 2021
Q3 2021 -21.1 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.